311 related articles for article (PubMed ID: 35955407)
1. Regulation of CD4
Schiweck C; Edwin Thanarajah S; Aichholzer M; Matura S; Reif A; Vrieze E; Weigert A; Visekruna A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955407
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?
Dong Y; Zhang K; Wei J; Ding Y; Wang X; Hou H; Wu J; Liu T; Wang B; Cao H
Front Immunol; 2023; 14():1158200. PubMed ID: 37122756
[TBL] [Abstract][Full Text] [Related]
3. Dual role of microbiota-derived short-chain fatty acids on host and pathogen.
Mirzaei R; Dehkhodaie E; Bouzari B; Rahimi M; Gholestani A; Hosseini-Fard SR; Keyvani H; Teimoori A; Karampoor S
Biomed Pharmacother; 2022 Jan; 145():112352. PubMed ID: 34840032
[TBL] [Abstract][Full Text] [Related]
4. Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells.
Luu M; Visekruna A
Eur J Immunol; 2019 Jun; 49(6):842-848. PubMed ID: 31054154
[TBL] [Abstract][Full Text] [Related]
5. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the effector function of CD8
Luu M; Weigand K; Wedi F; Breidenbend C; Leister H; Pautz S; Adhikary T; Visekruna A
Sci Rep; 2018 Sep; 8(1):14430. PubMed ID: 30258117
[TBL] [Abstract][Full Text] [Related]
7. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
Duan H; Wang L; Huangfu M; Li H
Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
[TBL] [Abstract][Full Text] [Related]
8. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity.
Yang W; Yu T; Huang X; Bilotta AJ; Xu L; Lu Y; Sun J; Pan F; Zhou J; Zhang W; Yao S; Maynard CL; Singh N; Dann SM; Liu Z; Cong Y
Nat Commun; 2020 Sep; 11(1):4457. PubMed ID: 32901017
[TBL] [Abstract][Full Text] [Related]
9. Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.
Kibbie JJ; Dillon SM; Thompson TA; Purba CM; McCarter MD; Wilson CC
Immunobiology; 2021 Sep; 226(5):152126. PubMed ID: 34365090
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy.
Luu M; Monning H; Visekruna A
Front Immunol; 2020; 11():1225. PubMed ID: 32612610
[TBL] [Abstract][Full Text] [Related]
11. The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis.
Barcutean L; Maier S; Burai-Patrascu M; Farczadi L; Balasa R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542172
[TBL] [Abstract][Full Text] [Related]
12. Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases.
Rasouli-Saravani A; Jahankhani K; Moradi S; Gorgani M; Shafaghat Z; Mirsanei Z; Mehmandar A; Mirzaei R
Biomed Pharmacother; 2023 Jun; 162():114620. PubMed ID: 37004324
[TBL] [Abstract][Full Text] [Related]
13. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.
Boets E; Gomand SV; Deroover L; Preston T; Vermeulen K; De Preter V; Hamer HM; Van den Mooter G; De Vuyst L; Courtin CM; Annaert P; Delcour JA; Verbeke KA
J Physiol; 2017 Jan; 595(2):541-555. PubMed ID: 27510655
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of microbiota-derived short-chain fatty acids in immunometabolism.
Abdalkareem Jasim S; Jade Catalan Opulencia M; Alexis Ramírez-Coronel A; Kamal Abdelbasset W; Hasan Abed M; Markov A; Raheem Lateef Al-Awsi G; Azamatovich Shamsiev J; Thaeer Hammid A; Nader Shalaby M; Karampoor S; Mirzaei R
Int Immunopharmacol; 2022 Sep; 110():108983. PubMed ID: 35750016
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers.
Son MY; Cho HS
J Microbiol Biotechnol; 2023 Jul; 33(7):849-856. PubMed ID: 37100764
[TBL] [Abstract][Full Text] [Related]
17. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
19. Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids.
Kim CH
Cell Mol Immunol; 2021 May; 18(5):1161-1171. PubMed ID: 33850311
[TBL] [Abstract][Full Text] [Related]
20. Short-chain fatty acids inhibit the activation of T lymphocytes and myeloid cells and induce innate immune tolerance.
Porbahaie M; Hummel A; Saouadogo H; Coelho RML; Savelkoul HFJ; Teodorowicz M; van Neerven RJJ
Benef Microbes; 2023 Sep; 14(4):401-419. PubMed ID: 38661366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
